1-20 of 26
Authors: Sepideh Mokhtari
Journal Article
Phase 1 trial of hypofractionated stereotactic re-irradiation in combination with nivolumab, ipilimumab, and bevacizumab for recurrent high-grade gliomas Open Access
Neuro-Oncology Advances, Volume 7, Issue 1, January-December 2025, vdaf033, https://doi.org/10.1093/noajnl/vdaf033
Published: 08 February 2025
Journal Article
ANGI-07. A CASE OF HYPERBARIC OXYGEN USED AS A TREATMENT MODALITY FOR ANAPLASTIC ASTROCYTOMA Free
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii17, https://doi.org/10.1093/neuonc/noae165.0066
Published: 11 November 2024
Journal Article
NIMG-86. DISSEMINATEDCRYPTOCOCCUS NEOFORMANS MIMICKING CENTRAL NERVOUS SYSTEM PROGRESSION OF DIFFUSE LARGE B-CELL LYMPHOMA Free
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii215, https://doi.org/10.1093/neuonc/noae165.0850
Published: 11 November 2024
Journal Article
NCMP-28. CASE REPORT: REFRACTORY MYASTHENIA GRAVIS FLARE INDUCED BY IMMUNE CHECK POINT INHIBITOR Free
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Pages viii222–viii223, https://doi.org/10.1093/neuonc/noae165.0880
Published: 11 November 2024
Journal Article
INNV-37. BELZUTIFAN IMPACT ON VHL-ASSOCIATED CNS HEMANGIOBLASTOMAS Free
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v165, https://doi.org/10.1093/neuonc/noad179.0626
Published: 10 November 2023
Journal Article
SURG-26. HYDROCEPHALUS IN LEPTOMENINGEAL DISEASE: TANDEM OMMAYA RESERVOIR-SHUNT FOR INTRATHECAL CHEMOTHERAPY ADMINISTRATION Free
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v267, https://doi.org/10.1093/neuonc/noad179.1025
Published: 10 November 2023
Journal Article
TIPS-04 A RANDOMIZED, MULTI-INSTITUTIONAL PILOT STUDY TO EVALUATE THE MOLECULAR AND CELLULAR RESPONSE TO TREATMENT WITH NIVOLUMAB WITH EITHER ADJUVANT IPILIMUMAB OR RELATLIMAB IN ADULT PATIENTS WITH SURGICALLY RESECTABLE MELANOMA BRAIN METASTASES: ONGOING TRIAL Open Access
Neuro-Oncology Advances, Volume 5, Issue Supplement_3, August 2023, Page iii34, https://doi.org/10.1093/noajnl/vdad070.135
Published: 04 August 2023
Journal Article
SYST-03 PHASE 1B STUDY OF AVELUMAB AND WHOLE BRAIN RADIOTHERAPY (WBRT) IN PATIENTS WITH LEPTOMENINGEAL DISEASE (LMD) FROM EPITHELIAL CARCINOMAS: FINAL RESULTS AND MOLECULAR ANALYSES WITH SINGLE CELL RNA SEQUENCING Open Access
Neuro-Oncology Advances, Volume 5, Issue Supplement_3, August 2023, Page iii28, https://doi.org/10.1093/noajnl/vdad070.111
Published: 04 August 2023
Journal Article
CNSC-03. NEURONAL INTERMEDIATE FILAMENT (NIF) ANTIBODY POSITIVE PARANEOPLASTIC SYNDROME IN A PATIENT WITH METASTATIC NEUROENDOCRINE PANCREATIC CARCINOMA AND TREATMENT WITH IPILIMUMAB/NIVOLUMAB Free
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii22, https://doi.org/10.1093/neuonc/noac209.084
Published: 14 November 2022
Journal Article
NCMP-17. PLASMA EXCHANGE FOR IMMUNE CHECKPOINT INHIBITOR INDUCED ACUTE DEMYELINATING POLYNEUROPATHY REFRACTORY TO IVIG Free
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii194, https://doi.org/10.1093/neuonc/noac209.745
Published: 14 November 2022
Journal Article
NCMP-16. UNIQUE PARANEOPLASTIC SYNDROME ASSOCIATED WITH CLL Free
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii194, https://doi.org/10.1093/neuonc/noac209.744
Published: 14 November 2022
Journal Article
CTIM-01. TITLE: PHASE 1B STUDY OF AVELUMAB AND WHOLE BRAIN RADIOTHERAPY (WBRT) IN PATIENTS WITH LEPTOMENINGEAL DISEASE (LMD): PRELIMINARY RESULTS Free
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii59, https://doi.org/10.1093/neuonc/noac209.233
Published: 14 November 2022
Journal Article
INNV-23. MANAGING CENTRAL NERVOUS SYSTEM MANIFESTATIONS OF CHRONIC GRAFT VERSUS HOST DISEASE FOLLOWING HEMATOPOIETIC STEM CELL TRANSPLANTATION: A CASE REPORT Free
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii146, https://doi.org/10.1093/neuonc/noac209.563
Published: 14 November 2022
Journal Article
NCMP-23. A UNIQUE CASE OF CHOREIFORM DYSKINESIAS IN A PATIENT WITH METASTATIC RENAL CELL CARCINOMA Free
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii196, https://doi.org/10.1093/neuonc/noac209.751
Published: 14 November 2022
Journal Article
Surgical and anatomic factors predict development of leptomeningeal disease in patients with melanoma brain metastases Free
Neuro-Oncology, Volume 24, Issue 8, August 2022, Pages 1307–1317, https://doi.org/10.1093/neuonc/noac023
Published: 29 January 2022
Journal Article
NCMP-08. CHALLENGING DIAGNOSIS AND MANAGEMENT OF PCNSL IN AN IMMUNOSUPPRESSED PATIENT ON MYCOPHENOLATE MOFETIL FOR MYASTHENIA GRAVIS Free
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Pages vi148–vi149, https://doi.org/10.1093/neuonc/noab196.581
Published: 12 November 2021
Journal Article
NCMP-21. IMMUNE-RELATED ACUTE MOTOR AXONAL NEUROPATHY: A SMALL CASE SERIES AND REVIEW OF THE LITERATURE Free
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Page vi151, https://doi.org/10.1093/neuonc/noab196.592
Published: 12 November 2021
Journal Article
BIOM-02. LEPTOMENINGEAL DISEASE SECONDARY TO MELANOMA: UPDATES ON THE VALIDITY OF THE VERIDEX CELLSEARCH SYSTEM Free
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Page vi10, https://doi.org/10.1093/neuonc/noab196.034
Published: 12 November 2021
Journal Article
LMD-05. Phase 1B Study of Avelumab and Whole Brain Radiotherapy (WBRT) in Patients with Leptomeningeal Disease (LMD): Preliminary Results Open Access
Neuro-Oncology Advances, Volume 3, Issue Supplement_3, August 2021, Page iii8, https://doi.org/10.1093/noajnl/vdab071.030
Published: 09 August 2021
Journal Article
Hypofractionated stereotactic re-irradiation with pembrolizumab and bevacizumab in patients with recurrent high-grade gliomas: results from a phase I study Free
Neuro-Oncology, Volume 23, Issue 4, April 2021, Pages 677–686, https://doi.org/10.1093/neuonc/noaa260
Published: 11 November 2020
